Sfoglia per AUTORE
LUPI A
Collezione ASL VCO
Items : 24
Inclisiran for fast-track lipid-lowering treatment early after an acute coronary syndrome: a pilot study in Atherosclerosis Plus
2025
ASL Torino 4
ASL Asti
ASL VCO
Lupi A; Baluci M; Persampieri S; Perversi I; Presutti D; Somaschini A; Gaudio GV; Guasti L; Ferrini M; Corsini A; De Ponti R;
Gender differences and hypercholesterolemia: real-world evidence from the study WECARE (Women Effective CArdiovascular Risk Evaluation) in Global and Regional Health Technology Assessment
2024
ASL VCO
ASL Vercelli
Perrone V; Medea G; Urbinati S; Sangiorgi D; Esposti LD; Andretta M; Bacca M; Barbieri A; Bartolini F; Caputo M; Cavaliere A; Ciaccia A; Costantini A; Ferrante F; Gentile S; Grego S; Lavalle A; Lupi A; Maccio S; Mancini D; Moscogiuri R; Procacci C; Re D; Santoleri F;
ORBITAL ATHERECTOMY FOR THE TREATMENT OF SEVERELY CALCIFIED CORONARY ARTERY STENOSIS: INSIGHTS FROM THE PROSPECTIVE, MULTICENTER, REAL-WORLD ROLLINGSTONE REGISTRY in Giornale Italiano di Cardiologia
2024
ASL VCO
ASL Vercelli
Pavani M; Cerrato E; Giacobbe F; Buccheri G; Tomassini F; Franzé A; Siliano S; Maffi V; Rolfo C; Piedimonte G; Zecchino S; Novarese F; Bosco M; Spissu PMP; Elia E; Zanda G; Taglialatela V; Bruno F; Verdoia M; Jeva F; Doronzo M; Abdirashid M; Lupi A; Patti G; Porto I; Musumeci G; Varbella F;
Coronary calcification in patients presenting with acute coronary syndromes: insights from the MATRIX trial. in European heart journal. Acute cardiovascular care / Eur Heart J Acute Cardiovasc Care. 2023 Nov 16;12(11):782-791. doi: 10.1093/ehjacc/zuad122.
2023
ASL Città di Torino
ASL VCO
ASL Torino 3
van 't Hof A; Tosi P; Zingarelli A; Rigattieri S; de Cesare N; Tresoldi S; Varbella F; Sardella G; Santarelli A; Esposito G; Ierna S; Ausiello A; Cortese B; Lupi A; Russo F; Sganzerla P; Garbo R; Limbruno U; Repetto A; Andò G; Briguori C; Rubartelli P; Garducci S; Calabrò P; Gagnor A; Leonardi S; Frigoli E; Branca M; Garcia-Garcia HM; et alii...
Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug-Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA). in Therapeutics and clinical risk management / Ther Clin Risk Manag. 2023 Jan 18;19:57-65. doi: 10.2147/TCRM.S394467. eCollection 2023.
2023
ASL VCO
Fagiuoli S; Toniutto P; Coppola N; Ancona DD; Andretta M; Bartolini F; Ferrante F; Lupi A; Palcic S; Rizzi FV; Re D; Alvarez Nieto G; Hernandez C; Frigerio F; Perrone V; Degli Esposti L; Mangia A;
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia in Journal of the American Heart Association
2023
ASL Asti
ASL VCO
Olmastroni E; Gazzotti M; Averna M; Arca M; Tarugi P; Calandra S; Bertolini S; Catapano AL; Casula M; D’Erasmo L; Cefalu AB; Bartuli A; Buonuomo PS; Benso A; Beccuti G; Biasucci G; Capra ME; Biolo G; Vinci P; Bonanni L; Borghi C; D’Addato S; Bossi AC; Meregalli G; Branchi A; Calabro P; Carubbi F; Nascimbeni F; Cipollone F; et alii...
The Influence of Iron-Deficiency Anaemia (IDA) Therapy on Clinical Outcomes and Healthcare Resource Consumptions in Chronic Kidney Disease Patients Affected by IDA: A Real-Word Evidence Study among the Italian Population. in Journal of clinical medicine / J Clin Med. 2022 Sep 30;11(19):5820. doi: 10.3390/jcm11195820.
2022
ASL VCO
Perrone V; Veronesi C; Dovizio M; Ancona DD; Bartolini F; Ferrante F; Lupi A; Palcic S; Re D; Terlizzi AP; Ramirez de Arellano Serna A; Cogliati P; Degli Esposti L;
Real-World Evaluation of Calcimimetics for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease, in an Italian Clinical Setting. in Healthcare (Basel, Switzerland) / Healthcare (Basel). 2022 Apr 11;10(4):709. doi: 10.3390/healthcare10040709.
2022
ASL VCO
Perrone V; Dovizio M; Veronesi C; Andretta M; Bartolini F; Cavaliere A; Ferrante F; Lupi A; Pagliaro R; Pagnotta R; Palcic S; Re D; Ubertazzo L; Vercellone A; Degli Esposti L;
Direct Healthcare Costs by Level of Adherence of a Real-World Population of Statin Users in Italy. in ClinicoEconomics and outcomes research : CEOR / Clinicoecon Outcomes Res. 2022 Mar 10;14:139-147. doi: 10.2147/CEOR.S345852. eCollection 2022.
2022
ASL VCO
Degli Esposti L; Veronesi C; Ancona DD; Andretta M; Bartolini F; Drei A; Lupi A; Palcic S; Re D; Rizzi FV; Giacomini E; Perrone V;
Evaluation of the Therapeutic Pattern and Pharmaco-Utilization in Hypercholesterolemic Patients Treated with Statins: A Retrospective Study on Italian Real-World Data. in Risk management and healthcare policy / Risk Manag Healthc Policy. 2022 Jul 28;15:1483-1489. doi: 10.2147/RMHP.S358015. eCollection 2022.
2022
ASL VCO
Perrone V; Giacomini E; Sangiorgi D; Andretta M; Bartolini F; Lupi A; Ferrante F; Palcic S; Re D; Degli Esposti L;
CORONARY MICROVASCULAR DYSFUNCTION: IT COULD BE (ALSO) A MAN'S WORLD! in European Heart Journal, Supplement
2022
ASL VCO
Persampieri S; Baluci M; Schaffer A; De Martino L; De Pace D; Lupi A;
Impact of polypharmacy and aging on the risk of multiple drug-drug interactions (DDIs) in HCV patients treated with pangenotypic direct-acting antivirals (pDAA) in Digestive and Liver Disease
2022
ASL VCO
Mangia A; Toniutto P; Coppola N; Ancona DD; Andretta M; Bartolini F; Ferrante F; Lupi A; Palcic S; Rizzi FV; Re D; Nieto GA; Hernandez C; Perrone V; Esposti LD; Fagiuoli S;
2022
ASL VCO
Perrone V; Veronesi C; Giacomini E; Alessandrini D; Ancona DD; Andretta M; Bartolini F; Ferrante F; Lupi A; Palcic S; Re D; Terlizzi AM; Ramirez de Arellano Serna A; Wächter S; Degli Esposti L;
2021
ASL Asti
ASL VCO
Vallejo-Vaz AJ; Stevens CAT; Lyons ARM; Dharmayat KI; Freiberger T; Hovingh GK; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Alhabib KF; Alkhnifsawi M; Almahmeed W; Alnouri F; Alonso R; Al-Rasadi K; Al-Sarraf A; Al-Sayed N; Araujo F; Ashavaid TF; Banach M; Béliard S; Benn M; Binder CJ; Bogsrud MP; Bourbon M; et alii...
Alcohol Consumption and Acute Coronary Syndrome: "In vino Veritas". in Cardiology / Cardiology. 2020;145(12):766-768. doi: 10.1159/000509417. Epub 2020 Aug 7.
2020
ASL VCO
Persampieri S; Schaffer A; De Martino L; Valli F; Lupi A;
Long-term prognostic value of high systolic pulmonary arterial pressure after acute pulmonary embolism: A retrospective study in Giornale Italiano di Cardiologia
2020
ASL VCO
Persampieri S; Schaffer A; Tessitori M; De Martino L; Anchisi C; Tommasi S; De Pace D; Alfieri A; Lupi A;
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial. in Lancet (London, England)
2018
ASL VCO
ASL Torino 3
Valgimigli M; Frigoli E; Leonardi S; Vranckx P; Rothenbühler M; Tebaldi M; Varbella F; Calabrò P; Garducci S; Rubartelli P; Briguori C; Andó G; Ferrario M; Limbruno U; Garbo R; Sganzerla P; Russo F; Nazzaro M; Lupi A; Cortese B; Ausiello A; Ierna S; Esposito G; Ferrante G; Santarelli A; Sardella G; de Cesare N; Tosi P; van 't Hof A; et alii...
Early P2Y12 Inhibitors Escalation in Primary PCI Patients: Insights from the RENOVAMI Registry. in Thrombosis and haemostasis / Thromb Haemost. 2018 May;118(5):852-863. doi: 10.1055/s-0038-1635578. Epub 2018 Apr 4.
2018
ASL VCO
AO Ordine Mauriziano
Alexopoulos D; Guasti L; Gaudio G; Bongo AS; Schaffer A; Capodanno D; Meliga E; Bona RD; Lupi A; Valgimigli M; Porto I;
Determinants of radiation dose during right transradial access: Insights from the RAD-MATRIX study. in American heart journal / Am Heart J. 2018 Feb;196:113-118. doi: 10.1016/j.ahj.2017.10.014. Epub 2017 Oct 28.
2018
ASL VCO
Sciahbasi A; Frigoli E; Sarandrea A; Calabrò P; Rubartelli P; Cortese B; Tomassini F; Zavalloni D; Tebaldi M; Calabria P; Rigattieri S; Zingarelli A; Sardella G; Lupi A; Rothenbühler M; Heg D; Valgimigli M;
Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RAD-Matrix Trial. in Journal of the American College of Cardiology / J Am Coll Cardiol. 2017 May 23;69(20):2530-2537. doi: 10.1016/j.jacc.2017.03.018. Epub 2017 Mar 18.
2017
ASL VCO
Sciahbasi A; Frigoli E; Sarandrea A; Rothenbühler M; Calabrò P; Lupi A; Tomassini F; Cortese B; Rigattieri S; Cerrato E; Zavalloni D; Zingarelli A; Calabria P; Rubartelli P; Sardella G; Tebaldi M; Windecker S; Jüni P; Heg D; Valgimigli M;
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients. in Drug design, development and therapy / Drug Des Devel Ther. 2017 Aug 4;11:2293-2300. doi: 10.2147/DDDT.S134826. eCollection 2017.
2017
ASL VCO
Guasti L; Gaudio G; Lupi A; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Sarzani R; Vanasia M; Maffioli P; Derosa G;
2017
ASL VCO
Gaudio GV; De Rosa G; Lupi A; Davino A; Sala C; Mugellini A; Vulpis V; Felis S; Vanasia M; Guasti L; Gaudio G;
Intracoronary Bivalirudin Bolus in ST-Elevation Myocardial Infarction Patients Treated with Primary Angioplasty: Theoretical Bases, Clinical Experience, and Future Applications. in American journal of cardiovascular drugs : drugs, devices, and other interventions / Am J Cardiovasc Drugs. 2016 Dec;16(6):391-397. doi: 10.1007/s40256-016-0186-z.
2016
ASL Vercelli
ASL VCO
AOU Novara
Porto I; Jaffe AS; Cortese B; Bongo AS; Cavallino C; Rognoni A; Schaffer A; Angiolillo DJ; Lupi A;
Pre-hospital ticagrelor in patients with ST-segment elevation myocardial infarction with long transport time to primary PCI facility. in Cardiovascular revascularization medicine : including molecular interventions / Cardiovasc Revasc Med. 2016 Dec;17(8):528-534. doi: 10.1016/j.carrev.2016.08.005. Epub 2016 Aug 20.
2016
ASL VCO
AOU Novara
De Martino L; Rognoni A; Tessitori M; Lazzero M; Schaffer A; Lupi A; Bongo AS; Porto I;